ADVERTORIAL
Could This Company be the “Future Oatly” of the $109.1 Billion Infant Formula Market?
With a global patent for the world’s first 100% plant-based dairy and soy-free infant formula alternative, this little-known company could be the next plant juggernaut
In 2015, Sweden’s dairy lobby – LRF Mjölk – sued oat milk producer Oatly for suggesting that milk is harmful in its advertising1.
LRF Mjölk won the lawsuit, and Oatly was forced to pay the group £100,000 and stop using the slogan, “Milk, but made for humans”, in Sweden.
It was one of the most spectacular backfires in business history.
Oatly seized this as a marketing advantage, publishing the text of the lawsuit and even using the banned slogan in a large-scale advertising campaign in the UK2.
You may already know how the rest of the story goes.
In July 2020, Oatly raised $200 million from a consortium of investors led by Blackstone Group, which included celebrities like Oprah Winfrey, Jay-Z, Natalie Portman, and Starbucks founder Howard Schultz.3
Oatly’s valuation? An impressive $2 billion.
But that was just the beginning.
As the plant-based food megatrend accelerated and investor interest turned to frenzy, Oatly decided to go public just 10 months later, on May 19, 2021.
Its IPO was a resounding success, raising $1.4 billion at a $10 billion valuation4.
Less than a month after its IPO, Oatly’s market cap broke $17 billion on June 11, 20215.
Oatly’s story is no doubt incredible.
But with an IPO valuation of $10 billion, it’s clear who the real winners were – the wealthy and connected private investors who could buy their way in before the public ever had a chance – and reap gains of 850% in 11 months.
But what if:
You Could be an Early Investor in a Company that Could Potentially be the “Future Oatly” of the $109.1 Billion Infant Formula Market?
Oatly’s growth story has eerie parallels with a company that is disrupting the infant nutrition market with its globally patented formula for the world’s first 100% plant-based dairy and soy-free infant formula alternative.
A market that Fortune Business Insights expects to surge from $50.5 billion in 2019 to $109.1 billion in 20276.
They both hold patents78 that grant them powerful competitive advantages (although you’ll soon see why the company, we are discussing patents could be even more valuable).
They both had to expand US distribution to meet increasing demand.
And they’re both perfectly positioned to benefit from the plant-based food revolution that is sweeping the world.
Of course, there are differences.
The new company in which we are discussing is just at the beginning of its growth story.
And because it went public early, regular investors still have the chance to get in before the company’s valuation potentially goes parabolic.
As of June 11, 2021, its valuation is still under C$250 million9, with most of its potential still ahead.
Plus, unlike Oatly, this company has no true competition.
Why? Because there are no other plant-based infant formula alternatives that don’t use soy and are nutritionally equivalent to breast milk.
Which is why the company could permanently disrupt the $109.1 billion infant formula market – and become the next plant juggernaut in the process.
The Dairy and Soy-Filled Infant Formula Market has Placed Caring Parents in an Almost Unconscionable Dilemma
Over 11% of US parents already think their children have food allergies. And 40% of baby formulas sold in the country are specialty cow’s milk formulas catering for allergies and intolerances10.
On top of this, an estimated 50% of children with food allergies are allergic to cow’s milk.
This is why Grandview Research expects the market for lactose-free infant formula to hit $24 billion by 202411.
Especially when you consider that there are many reasons parents may prefer lactose-free or dairy free formula even when their child isn’t allergic to milk.
The problem? The main alternative being used is soy, which in many ways, could be even worse.
This puts the many parents who have no choice but to formula feed their children in an almost unconscionable dilemma – choosing between dairy and soy.
And with awareness of the multiple benefits of plant-based foods quickly spreading, the infant formula market is crying out for a safe and authentic plant-based solution.
With its Patented One-of-a-Kind Formula, This Company Could be the Answer Millions of Parents are Looking For
This company has taken an entirely different – and better – route.
The company’s proprietary formula is made with a combination of almond, buckwheat, and tapioca – bypassing the allergen issues present with dairy and soy while also being 100% vegan-friendly.
It has also overcome the primary challenge for all infant formula alternatives – meeting the human-milk nutritional gold standard – on top of ensuring a breakthrough “clean label” manufacturing process with no chemicals or solvents involved.
This company is already a recipient of The Clean Label Project Purity Award12, which requires testing for over 400 contaminants and heavy metals.
And by protecting its proprietary formula with global patents, this company has ensured that it could be the only legitimate soy-free and plant-based infant formula alternative on the market based on its proprietary composition for years to come.
8 Reasons Why This Company Could be on the Verge of Permanently Disrupting the $109.1 Billion Infant Nutrition Market
- More and More People are Realizing That Dairy and Soy may not be Ideal for a Large Proportion of Infants. A study of 51,819 US households revealed that 11.4% of parents believed their children had food allergies13. Both dairy and soy protein are problematic sources of allergens for this sensitive population – not to mention the fact that they are often highly processed and non-organic.
- It Holds a Global Patent for the World’s First 100% Plant-based Dairy and Soy-free Formula Alternative That is Nutritionally Equivalent to Breast Milk. There are plenty of non-dairy formulas out there. The problem? They mostly use soy, which presents its own set of problems. Until this company did it, no one had figured out the “recipe” to a soy and dairy-free alternative that can meet all an infant’s nutritional needs. And thanks to its global patent, the company could be the only one in the market for years to come.
- It’s Constantly Winning New Distributors Who Can’t Wait to Stock Its One-of-a-Kind Award-Winning Product. Mother’s Market, Associated Food Stores, Raley’s, PCC Community Markets, Haggen Food & Pharmacy, Vitamin Cottage Natural Grocers, and Big Y are just the distributors that have come onboard since April 2021. This is on top of big distributors like KeHE, United Natural Foods, and Sprouts Farmers Market, not to mention the company’s online presence through global sites like Amazon, iHerb, and PlantX14.
- The Majority of its Product Line is Still Yet to be Launched. This company is already making a splash on the infant nutrition market with its current product line – but it’s just getting started. Over the next year alone, the company plans to launch four more product lines15.
- It’s Performing Clinical Research to Clinically Validate its Claims – Which Would Give it an Unstoppable Marketing Advantage. Not content with its multiple awards and global patents, this company is also performing clinical research to validate its clinical claims for its products on growth, hypoallergenicity, and good tolerance16. If successful, this would give it a marketing edge that could be unstoppable. Remember that Oatly became a $17 billion company in large part thanks to marketing.
- Already has Proven Support from Powerful Strategic Investors. The company has a combined C$41.2 million171819 from investment bank Canaccord Genuity and H&H Group, a global health and nutrition company listed in Hong Kong with a multi-billion dollar market cap20.
- Its Technological and Intellectual Property Portfolio is a Strong Foundation for This Company to Eventually Become a Global Nutrition Powerhouse. The company’s patent portfolio is immensely valuable by itself. But it also has the specialized technology infrastructure necessary for its “clean label” and whole food ingredients manufacturing process that also only uses all-natural enzymatic or mechanical procedures – with no chemicals or solvents involved. Those two combined could be the foundational infrastructure for a future global nutrition powerhouse.
- Guided by a Highly Skilled Management Team with Deep Experience in the Nutrition Industry. The company’s management team has decades of experience in the nutrition industry, giving them a keen understanding of what it takes to scale a nutrition company from niche market to mass consumption. This companies management is also guided by an immensely qualified scientific advisory board comprising doctors, professors, and PhDs.
The Next Global Nutrition Powerhouse
The foundations of a global nutrition powerhouse are already there.
This company already has a highly valuable patent portfolio for a one-of-a-kind product that the $109.1 billion infant formula market is crying out for.
Its clean-label proprietary manufacturing process – its technological foundation – is also patent pending21, which will further enhance the value of its patent portfolio.
Add this company’s accelerating growth, proven support from strategic investors, and C$19.6 million in the bank (with zero debt)22 – and you could be looking at the next plant-based juggernaut.
Enter your email address below to learn more about this fast-developing story.
Legal Notice: This website is owned and hosted by Market Tactic Media Ltd. Articles appearing on this website should be considered paid advertisements. Market Tactic Media Ltd. and its owners, managers, employees, and assigns (collectively “the Website Host”) is often paid by marketing companies to host websites on which articles profiling public companies are published. The articles on this website are not, and should not be construed to be, offers to sell or solicitations of an offer to buy any security. Neither the articles on this website nor the Website Host purport to provide a complete analysis of any company or its financial position. The Website Host is not, and does not purport to be, a broker-dealer or registered investment adviser. The articles on this website are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the profiled company’s SEC and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk.
